Book a demo

Electrodialysis Ion-Exchange Membrane Patent Landscape 2026 | Patsnap

Electrodialysis Ion-Exchange Membrane Patent Landscape 2026 | Patsnap
https://www.patsnap.com/resources/blog/rd-blog/electrodialysis-ion-exchange-membrane-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Engineering
Electrodialysis Ion-Exchange Membrane Patent Landscape 2026
  • Activity peaked in 2024 at 126 families, then dropped sharply — a pattern suggesting that the field's latest growth wave has crested and consolidation is underway.
  • Bipolar-membrane chemistry dominates citation influence, with the most-cited records clustering around composite solid polymer electrolyte membranes, signalling dense prior art exactly where new entrants most often aim.
  • The US leads receiving offices by a wide margin, yet a strong China–EPO–Japan trio reflects genuinely global commercial interest and creates multi-jurisdiction freedom-to-operate complexity for any new programme.
Get a prior-art report on your approach
2,019
Published Records
14%
Top-5 Share of All Records
+174%
Filing Growth 2021→2024
US
Leading Jurisdiction

Filing growth compares 2021 (46 records) with 2024 (126) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 2,019 records in scope (CR5), not by the ranked leaders only.

Published byPatsnap Research··13 min readSourced from Patsnap Eureka
Technology Overview

Electrodialysis membranes: the IP terrain at a glance

Electrodialysis (ED) separates ionic species by driving them through ion-exchange membranes under an applied electric field. The technology spans desalination, acid and base recovery, food-grade purification, and — increasingly — electrochemical synthesis. Three membrane architectures structure most of the claim space: cation-exchange membranes, anion-exchange membranes, and bipolar membranes (BPMs), which combine both layers to split water and generate acids and bases simultaneously without added reagents. BPM-based electrodialysis has attracted disproportionate research attention because it enables circular-chemistry routes — for instance, regenerating acids and bases from salt streams — that align with industrial decarbonisation targets. The corpus sits at the intersection of polymer science, electrochemistry, and separation engineering, which is why the IPC composition spans from B01D separation processes all the way to C12P fermentation applications.

Filing activity across the 2,019 families in this corpus grew steadily from 2017 through a 2024 peak, then fell back. Because patent applications are typically published 18 months after filing, the most recent year's count is structurally understated and should not be read as a signal of declining interest on its own. What is more telling is the mid-period: filings in 2022 sat at roughly half the 2024 peak, implying that the acceleration was relatively recent and concentrated. The broad separation-process class B01D accounts for the vast majority of records, while water-treatment (C02F) and electrolytic synthesis (C25B) form substantial secondary clusters — a distribution that reflects both the established desalination market and the emerging green-chemistry applications pulling investment into the field.

IPC subclass composition of the electrodialysis ion-exchange membrane corpus
  1. 1TOKUYAMA CORP101
  2. 2SOLVAY SA54
  3. 3EVOQUA WATER TECHNOLOGIES LLC52
  4. 4ARCHER DANIELS MIDLAND CO45
  5. 5IONICS INC40
  6. 6EKA CHEMCIALS AB38
  7. 7BL TECHNOLOGY INC37
  8. 8BASF SE37
  9. 9RES INST OF IND SCI & TECH33
  10. 10POSCO HLDG INC31
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Electrodialysis – Ion-Exchange Membrane covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Filing Trends & Data

What the numbers say about momentum and geography

The filing trajectory and geographic spread of this corpus reveal where commercial expectations are highest and where prosecution strategies diverge. Neither trend tells the full story without the other: a jurisdiction preference signals where enforcement is expected, while the trend shape signals how confident filers are in near-term market return.

Filing trend: 2017–2026

Annual family counts rose from 39 in 2017 to a corpus peak of 126 in 2024 before pulling back in 2025–2026. The 2022 midpoint of 75 families sits almost exactly between the 2017 baseline and the 2024 high, indicating roughly linear growth through the middle of the period rather than a sudden surge. The most recent year's figure (14 published families as of the data cut-off) is structurally understated by publication lag and cannot be compared directly to earlier years. What matters strategically is the 2024 peak: it represents a cohort of filings that will define the claim landscape for the next decade of licensing and litigation.

Filing trend: 2017–20260387511315039201720182019202020212022202312620242025142026Most recent year is partial — publication lag means later filings are not yet visible.

Technology composition by IPC subclass

B01D separation processes dominate at 1,962 records — nearly the full corpus — confirming that examiners and filers alike classify this work primarily as a separation technology. C02F water treatment (712 records) and C25B electrolytic synthesis (313 records) form the two most significant secondary clusters. C07C acyclic compounds (273) and C08J polymer processing (250) reflect the membrane-material dimension of the field. The presence of C12P fermentation records (106) is notable: it marks the growing use of ED stacks in biorefinery and fermentation-acid recovery, a sub-area where the prior-art density is considerably lower than in the core desalination space.

Technology composition by IPC subclassB01D · Separation processes (filtrati…1,96297.2%C02F · Water & wastewater treatment71235.3%C25B · Electrolytic production of com…31315.5%C07C · Acyclic & carbocyclic compounds27313.5%C08J · Polymer processing & solutions25012.4%B01J · Chemical/physical processes & …20510.2%C01D · Alkali-metal compounds1808.9%C12P · Fermentation & enzymatic synth…1065.3%Other1,21560.2%

Shares are the percentage of the 2,019 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Electrodialysis – Ion-Exchange Membrane covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Electrodialysis – Ion-Exchange Membrane with Eureka

This page is one run against one query. Ask Eureka your own question about electrodialysis – ion-exchange membrane and every answer comes back with the patent numbers behind it.

Try Eureka
Key Patents

Foundational records shaping the claim landscape

Featured Record
US6527932B12003-03-04

Methods for producing or purifying onium hydroxides by means of electrodialysis

BASF AKTIENGESELLSCHAFT

The methods prepare or purify onium hydroxides of nitrogen, sulfur, or phosphorus using an electrodialysis apparatus whose cell units each contain a bipolar membrane and an anion-selective membrane, with an additional bipolar or cation-selective membrane positioned on the anode side between the last anion-selective membrane and the anode. The architecture enables selective ion transport and pH control without exogenous reagents.Abstract condensed from the published specification. Patent number, assignee (BASF Aktiengesellschaft), and filing details are rendered from the dataset.

US6527932B1 — patent drawing 1US6527932B1 — patent drawing 2
View full record in Patsnap Eureka →
Most-cited patent families in the corpus
#Publication no.Patent titleCitations
1US6248469B1Composite solid polymer electrolyte membranes408
2US7550216B2Composite solid polymer electrolyte membranes366
3US6221225B1Apparatus and process for electrodialysis of salts196
4US4024043ASingle film, high performance bipolar membrane173
5US20020045085A1Composite solid polymer elecrolyte membranes162
6US5891328AMembrane-frame for processes including electrodialysis133
7US20040055955A1Production of purified water and high value chemicals from salt water132
8US20110203929A1Recovery of lithium from aqueous solutions127
9JP2009269810AMethod for producing high-purity lithium hydroxide127
10US7083730B2Production of purified water and high value chemicals from salt water127

Citation counts within a searched corpus favour older records — a document cited 400 times has had years more opportunity to accumulate references than one filed in 2022. Treat these figures as influence signals, not current-importance rankings. The full table with patent numbers, assignees, and citation counts is rendered from the underlying dataset.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Electrodialysis – Ion-Exchange Membrane covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis

 
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Landscape Insights

Reading the signals: density, influence, and collaboration

Three lenses illuminate this corpus beyond a simple headcount: where citation weight is concentrated (influence), how collaboration is structured (co-assignment), and what the technology mix implies for freedom to operate. Each lens points to a different risk or opportunity.

Citation concentration
408 citations
highest single-record citation count in the corpus

Prior art is dense at the composite-membrane core

The most-cited records cluster around composite solid polymer electrolyte membranes, with the top record attracting 408 citations and the next four all exceeding 160. This density is a direct map of where claim space is most contested. New filers targeting composite BPM architecture face a thick prior-art thicket that constrains both claim breadth and freedom to operate.

Strategy implication: differentiate on membrane integration method, stack geometry, or application-specific selectivity rather than base polymer composition.
Geographic reach
5 major offices
US · CN · EPO · JP · WIPO all receiving significant filings

Multi-jurisdiction prosecution is the norm, not the exception

The US leads receiving offices (413 records), but China (295), the EPO (278), and Japan (252) are each substantial. WIPO PCT filings (157) confirm that filers are actively preserving options across markets before committing to national-phase costs. A freedom-to-operate opinion that covers only one jurisdiction will miss material risk.

Strategy implication: any new product launch in water treatment or green chemistry should carry at minimum a US–CN–EPO clearance review.
Collaboration network
10 co-assignee pairs
documented in the corpus

Industry–industry partnerships dominate co-filing

The strongest co-assignee relationship links POSCO Research Institute of Industrialscience (RIST) with POSCO Holdings at 19 jointly-assigned families — a company-internal pairing that signals coordinated IP strategy across a corporate group rather than external technology transfer. The Solvay–EDF pairing (17 families) represents a genuine cross-sector collaboration between a specialty-chemicals major and a utility, pointing to industrial-scale acid–base recovery as a shared commercial target.

Strategy implication: watch these pairings as leading indicators of where joint ventures or licensing discussions may already be underway.
Application breadth
C12P: 106 records
fermentation and enzymatic synthesis sub-cluster

Biorefinery is an emerging but under-patented application

The C12P fermentation sub-cluster (106 records) is large enough to be deliberate but small enough to contain genuine white space. ED membrane technology applied to organic-acid recovery from fermentation broths — lactic acid, succinic acid, itaconic acid — sits at the junction of biorefinery economics and membrane science. Citation density here is far lower than in the desalination core, making it a more navigable space for new entrants with application-specific claims.

Strategy implication: application-specific claims tied to fermentation conditions, pH profiles, or specific organic-acid selectivity may face lower obviousness hurdles than equivalent general-chemistry claims.
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to electrodialysis – ion-exchange membrane, with the prior art for and against each one.

Find the white space →
Co-assignee collaboration network
AssigneeCo-assigneeShared families
POSCO Research Institute of Industrialscience (RIST)POSCO Holdings Inc.19
Solvay SAÉlectricité de France SA (EDF)17
Tokuyama CorporationDaio Paper Corporation3
Anixter International Inc.ZHENG YONGCHANG3
Anixter International Inc.MACDONALD RUSSELL J3
Anixter International Inc.JU ALEX3
POSCO Research Institute of Industrialscience (RIST)POSCO (Pohang Iron and Steel Co., Ltd.)3
Tokuyama CorporationSnow Brand Meg Milk Co., Ltd.2

Ten co-assignee pairs are documented in the corpus. The POSCO group pairing (19 families) and the Solvay–EDF pairing (17 families) are the strongest. The Tokuyama–Daio Paper pairing (3 families) represents a smaller but industrially specific collaboration in paper-mill process chemistry. The network is sparse overall, indicating that most IP in this field is held and developed unilaterally — which in turn means fewer cross-licensing structures and potentially more aggressive enforcement postures.

Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Electrodialysis – Ion-Exchange Membrane covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Key Players

Who holds position and where momentum has stalled

The assignee landscape is concentrated at the top — a small number of organisations account for a disproportionate share of families — followed by a long tail of single- or low-filing entrants. Recent-year momentum data tells a more sobering story: several of the historically active assignees recorded zero families in the latest available year, suggesting either portfolio maturation, strategic reorientation, or a shift toward trade-secret protection over patenting.

Filing concentration
Long tail of single-filing entrants
alongside a concentrated top tier

The top tier holds structural advantages

Organisations that built large portfolios through the growth phase of 2017–2024 now sit on estates that function as both defensive shields and licensing leverage. New entrants face the dual challenge of navigating existing claim scope and building enough of their own portfolio to achieve freedom to operate through cross-licensing.

Portfolio size alone does not confer immunity — design-around opportunities exist, but they require careful claim mapping.
Recent-year momentum
0 families in latest year
across multiple historically active assignees

Established players have paused — or pivoted

Multiple assignees that were active through 2023 recorded zero published families in the most recent year. Evoqua Water Technologies showed a -100% year-on-year change. This may reflect publication lag (filings from late 2024 not yet published), deliberate portfolio capping, or a strategic shift away from foundational claims toward trade-secret protection of process parameters.

Zero recent filings from a historically active assignee is an ambiguous signal — it warrants monitoring, not immediate conclusions.
Cross-sector presence
C25B: 313 records
electrolytic synthesis sub-cluster

Chemical-production majors compete alongside water specialists

The C25B electrolytic synthesis cluster (313 records) draws in chemical-production companies whose primary interest is not water treatment but acid–base or chlor-alkali synthesis. This cross-sector competition means that a water-treatment company's freedom to operate may be constrained by claims originally written for an entirely different end-use — a hazard that a technology-specific FTO search can easily miss.

Cross-classification searches across B01D and C25B are essential for any FTO opinion in this space.
🔍
Under-claimed sub-areas worth monitoring
These adjacent branches show lower prior-art density relative to the core desalination and chlor-alkali claim space. Each represents a potential first-mover opportunity for application-specific or material-specific claims.
Organic-acid recovery from fermentation brothsBPM-mediated CO₂ electrolysis product separationSelective lithium-ion transport membranes for brineED stack integration with reverse-osmosis brine concentrationMembrane antifouling via surface-grafted zwitterionic layersElectrodialysis reversal for produced-water treatment
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
Tokuyama Corporation0
Solvay SA0
Anixter International Inc.0
Evoqua Water Technologies LLC0-100%
Archer-Daniels-Midland Company (ADM)0
Eka Chemicals AB0
BASF SE0
POSCO Research Institute of Industrialscience (RIST)0-100%
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Electrodialysis – Ion-Exchange Membrane covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's Next

From landscape to decision

A landscape analysis is the starting point, not the endpoint. The practical moves — claim mapping, FTO opinions, prosecution strategy, and competitive monitoring — all depend on going deeper than aggregate counts. These are the natural next steps for an R&D lead or IP counsel working in this space.

Map the claim scope of the highest-cited families

The composite solid polymer electrolyte membrane records at the top of the citation ranking set the outer boundary of what cannot be claimed without a licence or a successful challenge. A claim-level analysis of those families — not just the abstract — reveals exactly which structural features, process conditions, and application contexts are blocked, and where the gaps are.

Explore claim mapping in Patsnap Eureka →

Run a cross-classification FTO search

Because this field spans B01D, C25B, C08J, and C07C, a single-class search will miss material risk. A properly scoped FTO opinion needs to track claims across all relevant subclasses and across the five major receiving offices identified in this corpus.

Start an FTO search in Patsnap Eureka →

Monitor the zero-momentum assignees

Several historically active filers recorded no published families in the most recent year. This may be temporary — publication lag masks 2024–2025 filings — or it may signal a strategic shift. Setting up assignee-level monitoring alerts means you will know which interpretation is correct as soon as new publications appear.

Set up assignee monitoring in Patsnap Eureka →

Identify prosecution opportunities in the fermentation sub-cluster

The C12P fermentation cluster (106 records) has substantially lower citation density than the desalination core. Application-specific claims tied to organic-acid selectivity, fermentation-broth pH profiles, or bioreactor-integrated ED configurations may face weaker prior art and therefore achieve broader allowable scope.

Analyse the fermentation sub-cluster in Patsnap Eureka →
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Electrodialysis – Ion-Exchange Membrane covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Frequently Asked Questions

Practitioner questions about the electrodialysis ion-exchange membrane patent landscape

Answers are grounded in the same dataset. Derived from a Patsnap search on Electrodialysis – Ion-Exchange Membrane covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Electrodialysis – Ion-Exchange Membrane in depth with Eureka

Go past this page: query the whole electrodialysis – ion-exchange membrane corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.